prof.dr. M.A.F.J. van de Laar (Mart)

Medicine & Life Sciences

# Antirheumatic Agents
# Arthritis
# Fatigue
# Gout
# Health
# Rheumatic Diseases
# Rheumatoid Arthritis
# Tumor Necrosis Factor Inhibitors

Faculty of Behavioural, Management and Social Sciences (BMS), Psychology, Health & Technology (PGT)

Epidemiology, farmacology and healtheconomics in rheumatic diseases.

Outcome research using ICT and IRT including computer adative tests.

see tihealthcare.nl

Fautrel, B., Wu, J., Wang, D., Haladyj, E. , Van De Laar, M. A. F. J., & Takeuchi, T. (2023). Relative Impact of Pain and Disease Activity on Improvements in Fatigue: Results From 2 Baricitinib Phase 3 Clinical Trials. Journal of Clinical Rheumatology, 29(3), 139-144. https://doi.org/10.1097/RHU.0000000000001924

van de Laar, M. A. F. J., Schöfl, R., Prevoo, M., & Jastorffi, J. (2023). Predictive value of gastrointestinal symptoms and patient risk factors for NSAID-associated gastrointestinal ulcers defined by endoscopy? Insights from a pooled analysis of two naproxen clinical trials. PLoS ONE, 18, 1-14. [e0284358]. https://doi.org/10.1371/journal.pone.0284358

Versteeg, G. A. (2022). The variability of rheumatoid arthritis: Balancing between population and individual. [PhD Thesis - Research UT, graduation UT, University of Twente]. University of Twente. https://doi.org/10.3990/1.9789464195156

van de Laar, C. J. , Janssen, C. A., Janssen, M. , Oude Voshaar, M. A. H., Maiwenn, J. AL. , & van de Laar, M. A. F. J. (2022). Model-based cost-effectiveness analyses comparing combinations of urate lowering therapy and anti-inflammatory treatment in gout patients. PLoS ONE, 17(1 January), [e0261940]. https://doi.org/10.1371/journal.pone.0261940

Voshaar, M. J. H., van den Bemt, B. J. F. , van de Laar, M. A. F. J., van Dulmen, A. M., & Vriezekolk, J. E. (2022). Healthcare professionals’ perceptions on barriers and facilitators to DMARD use in rheumatoid arthritis. BMC health services research, 22(1), [62]. https://doi.org/10.1186/s12913-021-07459-0

Versteeg, G. A. , ten Klooster, P. M. , & van de Laar, M. A. F. J. (2022). Fatigue is associated with disease activity in some, but not all, patients living with rheumatoid arthritis: disentangling “between-person” and “within-person” associations. BMC Rheumatology, 6(1), [3]. https://doi.org/10.1186/s41927-021-00230-2

Spijk-de Jonge, M. J., Weijers, J. M., Teerenstra, S., Elwyn, G. , van de Laar, M. A. F. J., van Riel, P. L. C. M., Huis, A. M. P., & Hulscher, M. E. J. L. (2022). Patient involvement in rheumatoid arthritis care to improve disease activity-based management in daily practice: A randomized controlled trial. Patient education and counseling, 105(5), 1244-1253. https://doi.org/10.1016/j.pec.2021.08.013

Versteeg, G. A. , Steunebrink, L. M. M. , Vonkeman, H. E. , ten Klooster, P. M., van der Bijl, A. E. , & van de Laar, M. A. F. J. (2022). Early radiological progression remains associated with long-term joint damage in real-world rheumatoid arthritis patients treated to the target of remission. Scandinavian journal of rheumatology, 51(2), 87-96. https://doi.org/10.1080/03009742.2021.1917161

Taylor, P. C. , Van De Laar, M., Laster, A., Fakhouri, W., Quebe, A., De La Torre, I., & Jain, S. (2021). Call for action: Incorporating wellness practices into a holistic management plan for rheumatoid arthritis - Going beyond treat to target. RMD Open, 7(3), [e001959]. https://doi.org/10.1136/rmdopen-2021-001959

Michaud, K., Pope, J. , van de Laar, M., Curtis, J. R., Kannowski, C., Mitchell, S., Bell, J., Workman, J., Paik, J., Cardoso, A., & Taylor, P. C. (2021). Systematic Literature Review of Residual Symptoms and an Unmet Need in Patients With Rheumatoid Arthritis. Arthritis Care and Research. https://doi.org/10.1002/acr.24369

1: Cost-Effectiveness of a JAK1/JAK2 Inhibitor vs a Biologic Disease-Modifying Antirheumatic Drug (bDMARD) in a Treat-to-Target Strategy for Rheumatoid Arthritis
Celine J Van De Laar, Martijn A H Oude Voshaar, Walid K H Fakhouri, Liliana Zaremba-Pechmann, Francesco De Leonardis, Inmaculada De La Torre, Mart A F J Van De Laar
Clinicoecon Outcomes Res. 2020; 12: 213–222. Published online 2020 Apr 15. doi: 10.2147/CEOR.S231558
PMCID: PMC7167259

2: International Consortium for Health Outcome Measurement Set of Outcomes That Matter to People Living With Inflammatory Arthritis: Consensus From an International Working Group
Martijn A. H. Oude Voshaar, Zofia Das Gupta, Johannes W. J. Bijlsma, Annelies Boonen, Jeffrey Chau, Delphine S. Courvoisier, Jeffrey R. Curtis, Benjamin Ellis, Sofia Ernestam, Laure Gossec, Christine Hale, Jennifer Hornjeff, Katy Y. Y. Leung, Merav Lidar, Phillip Mease, Kaleb Michaud, Girish M. Mody, Mwidimi Ndosi, Christina H. Opava, Geraldo R. C. Pinheiro, Matthew Salt, Enrique R. Soriano, William J. Taylor, Maria J. H. Voshaar, Angelique E. A. M. Weel, Maarten de Wit, Nico Wulffraat, Mart A. F. J. van de Laar, Harald E. Vonkeman
Arthritis Care Res (Hoboken) 2019 Dec; 71(12): 1556–1565. Published online 2019 Nov 29. doi: 10.1002/acr.23799
PMCID: PMC6900179

3: Psychometric properties and cross-language equivalence of the revised Bristol Rheumatoid Arthritis Fatigue and the Rheumatoid Arthritis Impact of Disease scales in rheumatoid arthritis
Martijn A. H. Oude Voshaar, Christina Bode, Sarah Hewlett, John Kirwan, Laure Gossec, Mart A. F. J. van de Laar
Qual Life Res. 2019; 28(9): 2543–2552. Published online 2019 Apr 26. doi: 10.1007/s11136-019-02188-8
PMCID: PMC6698264

4: A systematic literature review of patient-reported outcome measures used in gout: an evaluation of their content and measurement properties
Carly A. Janssen, Martijn A. H. Oude Voshaar, Peter M. ten Klooster, Tim L. Th. A. Jansen, Harald E. Vonkeman, Mart A. F. J. van de Laar
Health Qual Life Outcomes. 2019; 17: 63. Published online 2019 Apr 11. doi: 10.1186/s12955-019-1125-x
PMCID: PMC6460780

5: Development and preliminary evaluation of a short self-report measure of generalized pain hypersensitivity
Peter F van Bemmel, Martijn AH Oude Voshaar, Peter M ten Klooster, Harald E Vonkeman, Mart AFJ van de Laar
J Pain Res. 2019; 12: 395–404. Published online 2019 Jan 17. doi: 10.2147/JPR.S182287
PMCID: PMC6342225

6: Towards standardized patient reported physical function outcome reporting: linking ten commonly used questionnaires to a common metric
M. A. H. Oude Voshaar, H. E. Vonkeman, D. Courvoisier, A. Finckh, L. Gossec, Y. Y. Leung, K. Michaud, G. Pinheiro, E. Soriano, N. Wulfraat, A. Zink, M. A. F. J. van de Laar
Qual Life Res. 2019; 28(1): 187–197. Published online 2018 Oct 13. doi: 10.1007/s11136-018-2007-0
PMCID: PMC6339672

7: A retrospective analysis of medication prescription records for determining the levels of compliance and persistence to urate-lowering therapy for the treatment of gout and hyperuricemia in The Netherlands
C. A. Janssen, M. A. H. Oude Voshaar, H. E. Vonkeman, M. Krol, M. A. F. J. van de Laar
Clin Rheumatol. 2018; 37(8): 2291–2296. Published online 2018 May 2. doi: 10.1007/s10067-018-4127-x
PMCID: PMC6061072

8: Quality of care in gout: a clinical audit on treating to the target with urate lowering therapy in real-world gout patients
Carly A. Janssen, Tim L. Th. A. Jansen, Martijn A. H. Oude Voshaar, Harald E. Vonkeman, Mart A. F. J. van de Laar
Rheumatol Int. 2017; 37(9): 1435–1440. Published online 2017 Jul 26. doi: 10.1007/s00296-017-3777-3
PMCID: PMC5570767

9: Measuring everyday functional competence using the Rasch assessment of everyday activity limitations (REAL) item bank
Martijn A. H. Oude Voshaar, Peter M. ten Klooster, Harald E. Vonkeman, Mart A. F. J. van de Laar
Qual Life Res. 2017; 26(11): 2949–2959. Published online 2017 Jun 21. doi: 10.1007/s11136-017-1627-0
PMCID: PMC5655561

10: Initial combination therapy versus step-up therapy in treatment to the target of remission in daily clinical practice in early rheumatoid arthritis patients: results from the DREAM registry
L. M. M. Steunebrink, G. A. Versteeg, H. E. Vonkeman, P. M. ten Klooster, H. H. Kuper, T. R. Zijlstra, P. L. C. M. van Riel, M. A. F. J. van de Laar
Arthritis Res Ther. 2016; 18: 60. Published online 2016 Mar 8. doi: 10.1186/s13075-016-0962-9
PMCID: PMC4784382

See all research output of this employee

+31534899180 (secretary)

m.a.f.j.vandelaar@utwente.nl

Visiting Address

University of Twente
Faculty of Behavioural, Management and Social Sciences
Cubicus (building no. 41), room B125
De Zul 10
7522NJ Enschede
The Netherlands

Navigate to location

Mailing Address

University of Twente
Faculty of Behavioural, Management and Social Sciences
Cubicus B125
P.O. Box 217
7500 AE Enschede
The Netherlands

Faculty of Behavioural, Management and Social Sciences (BMS), Psychology, Health & Technology (PGT)

University of Twente Drienerlolaan 5
7522 NB Enschede

+31 (0)53 489 9111
info@utwente.nl
Route

Welcome...

prof.dr. M.A.F.J. van de Laar (Mart)

Professor

Expertise

Organisations

Research

Publications

UT Research Information System

Contact Details

Visiting Address

Mailing Address

Organisations